Quarterly report · Q1
6856.TEDINET S100QR7T
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥65.9bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥270.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥55.5bn | 2022-01-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥10.4bn | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥8.6bn | 2022-01-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥10.3bn | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥46.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.7bn | 2022-01-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥16.4bn | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥8.7bn | 2022-01-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥13.6bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.7bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥13.6bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥5.7bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥414.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥416.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥382.2bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥164.9bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥175.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥249.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥240.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥211.3bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥125.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥139.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥320.99 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥807.06 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥135.59 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥319.36 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥802.89 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥134.88 | 2022-01-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 60.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥15.9bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥15.9bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥330m |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥7.4bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥7.4bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥43m |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥5.4bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥5.4bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥529m |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥73m |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥29.0bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥29.0bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥9.7bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥13.7bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥13.7bn |
| jpcrp040300-q1r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥133m |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥6.7bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥6.7bn |
| jpcrp040300-q1r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥154m |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥4.8bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥4.8bn |
| jpcrp040300-q1r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥453m |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥683m |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥22.2bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥22.2bn |
| jpcrp040300-q1r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥7.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 398
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)羽津 隆弘 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)山田 徹雄 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)山中 智弘 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 55510000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 65854000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 270133000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 8743000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 10320000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 46860000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 5721000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 13556000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 34072000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 11077000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 15865000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 43153000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 211350000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 249114000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 240850000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 382235000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 414063000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 416742000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 135.59 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 320.99 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 807.06 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 134.88 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 319.36 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 802.89 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.5508 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.5998 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.5761 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 42532752 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 42532752 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 42532752 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 42532752 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 302500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 42210900 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 422109 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 19352 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 42532752 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 422109 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 302500 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 302500 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |